Innovation – Open view page

General information

Innovation ID562
Version ID432
Innovation TitleChickpea inbred variety Phule Vishwaraj for cultivation in dry lowlands in India
Innovation description Phule Vishwaraj is an early-maturing variety with semi-erect stand. it has high yield potential (1.6 to 2.8 mt/ha) with Fusarium wilt resistance, and drought tolerant making it suitable for rainfed condition. It`s dietary value is high digestibility, and high protein, iron and zinc content. this variety will potentially contribute to SDG`s 1,2,8,11,12, and 13.
Reporting Staff Srinivasan Samineni (ICRISAT)
Year (Reporting)2020
Reporting statusApproved
Innovation TypeGenetic (variety and breeds)
Number of varieties1

Stage reached

Stage of InnovationStage 3: available/ ready for uptake
Year (Stage)2020
Stage DescriptionFrom a cross made in 2009, followed by bulk selection (F1 to F5), and individual selection until advanced yield trials, Phule Vishwaraj was released for cultivation and ready for farmer uptake in Maharashtra, India on October 30, 2020. This variety is positioned to replace the older variety JAKI 9218.
Has a lead organizationyes
Lead OrganizationMahatma Phule Krishi Vidyapeeth Rahuri
Top 5 contributorsInternational Crops Research Institute for the Semi-Arid Tropics; Indian Council of Agricultural Research

Contributions and mapping

All partners
Main CRP CGIAR Research Program on Grain Legumes and Dryland Cereals
Flagship project FP4-Variety and Hybrid Development
Cluster FP4-2-Breeding pipelines
Other CRPs-Flagships-Clusters

Scope

Geographic scopeNational
Regions
CountriesIndia

Targeted outcomes

Main Sub-IDO Enhanced genetic gain
Other Sub-IDO Closed yield gaps through improved agronomic and animal husbandry practices
Other Sub-IDO Reduced production risk

Evidences

EvidencesList of varieties released by ICRISAT (GLDC-mapped) 2020 from MEASURE Platform
[https://mel.cgiar.org/uploads/relatedfiles/jhF3fH3GLzIx9UvsOqbzlMPwA0MDgf.xlsx]

Linked Elements

Milestones6814-172-37920 - New suite of resilient varieties released by NARS partners. (Phase 1 investments start being released)
Outcome Impact Case
Policy